Management of heparin-induced thrombocytopenia (HIT) in patients with systemic vasculitis and pulmonary haemorrhage

被引:5
|
作者
Thong, Kah Mean [1 ,2 ]
Toth, Peter [3 ]
Khwaja, Arif [1 ]
机构
[1] Sheffield Teaching Hosp Fdn Trust, Sheffield Kidney Inst, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Med Sch, Acad Nephrol Unit, Kidney Genet Grp, Sheffield, S Yorkshire, England
[3] Sheffield Teaching Hosp Fdn Trust, Dept Haematol, Sheffield, S Yorkshire, England
关键词
anti-glomerular membrane (GBM) glomerulonephritis; granulomatosis with polyangiitis; heparin-induced thrombocytopenia (HIT); thrombosis;
D O I
10.1093/ckj/sft075
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Heparin-induced thrombocytopenia (HIT) is a relatively uncommon but potentially fatal complication of the use of heparin in haemodialysis. It is associated with a risk of venous and arterial thrombosis due to the formation of a heparin-platelet factor 4 antibody. Early recognition and immediate treatment of HIT are crucial to reduce the morbidity and mortality rate. Here, we report two patients with acute kidney injury due to anti-glomerular membrane (GBM) glomerulonephritis and granulomatosis with polyangiitis respectively who developed haemoptysis and pulmonary haemorrhage complicated by HIT. We discuss the diagnostic and management challenges of such patients.
引用
收藏
页码:622 / 625
页数:4
相关论文
共 50 条
  • [1] Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis
    Roe, SD
    Cassidy, MJD
    Haynes, AP
    Byrne, JL
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (12) : 3226 - 3229
  • [2] Heparin-induced thrombocytopenia (HIT)
    Evans, Natalie S.
    Gomes, Marcelo
    VASCULAR MEDICINE, 2017, 22 (04) : 353 - 355
  • [3] Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis
    Alving, BM
    Krishnamurti, C
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (06) : 569 - 574
  • [4] Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management
    Hogan, Marie
    Berger, Jeffrey S.
    VASCULAR MEDICINE, 2020, 25 (02) : 160 - 173
  • [5] Adrenal haemorrhage due to heparin-induced thrombocytopenia
    Ketha, Siva
    Smithedajkul, Patrick
    Vella, Adrian
    Pruthi, Rajiv
    Wysokinski, Waldemar
    McBane, Robert
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) : 669 - 675
  • [6] Management of heparin-induced thrombocytopenia
    Jaax, Miriam E.
    Greinacher, Andreas
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (07) : 987 - 1006
  • [7] The management of heparin-induced thrombocytopenia
    Watson, Henry G.
    Keeling, David M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (02) : 269 - 269
  • [8] Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)
    Rauova, Lubica
    Arepally, Gowthami
    Poncz, Mortimer
    Cines, Douglas B.
    AUTOIMMUNITY REVIEWS, 2018, 17 (10) : 1046 - 1052
  • [9] Heparin-induced thrombocytopenia (HIT): Clinical and economic outcomes
    Baroletti, Steven
    Piovella, Chiara
    Fanikos, John
    Labreche, Matthew
    Lin, Jay
    Goldhaber, Samuel Z.
    THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) : 1130 - 1135
  • [10] Heparin-Induced Thrombocytopenia
    Szokol, Joseph W.
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2010, 14 (01) : 73 - 74